254 related articles for article (PubMed ID: 29460914)
21. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Ziegler D; Gries FA
Diabetes; 1997 Sep; 46 Suppl 2():S62-6. PubMed ID: 9285502
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of α-lipoic acid in diabetic neuropathy.
Papanas N; Ziegler D
Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
[TBL] [Abstract][Full Text] [Related]
23. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy.
Han Y; Wang M; Shen J; Zhang Z; Zhao M; Huang J; Chen Y; Chen Z; Hu Y; Wang Y
Minerva Endocrinol; 2018 Mar; 43(1):11-18. PubMed ID: 27901334
[TBL] [Abstract][Full Text] [Related]
24. A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy.
Han T; Bai J; Liu W; Hu Y
Eur J Endocrinol; 2012 Oct; 167(4):465-71. PubMed ID: 22837391
[TBL] [Abstract][Full Text] [Related]
25. The clinical efficacy of epalrestat combined with α-lipoic acid in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis.
Wang X; Lin H; Xu S; Jin Y; Zhang R
Medicine (Baltimore); 2018 Feb; 97(6):e9828. PubMed ID: 29419686
[TBL] [Abstract][Full Text] [Related]
26. The clinical effectiveness and safety of alprostadil combined with alpha lipoic acid in the treatment of diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis.
Guan H; Ye M; Fang C; Zhang L; Han P; Qiu S; Fang X; Li L
Medicine (Baltimore); 2020 Dec; 99(50):e23507. PubMed ID: 33327292
[TBL] [Abstract][Full Text] [Related]
27. A Case for Alpha-Lipoic Acid as an Alternative Treatment for Diabetic Polyneuropathy.
Nguyen N; Takemoto JK
J Pharm Pharm Sci; 2018; 21(1s):177s-191s. PubMed ID: 30139425
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of thiolepta in diabetic polyneuropathy: results of the study ETIKA].
Strokov IA; Fokina AS; Golovacheva VA; Kochetov AG
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):36-41. PubMed ID: 23739501
[TBL] [Abstract][Full Text] [Related]
29. The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy.
Jin HY; Joung SJ; Park JH; Baek HS; Park TS
Diabet Med; 2007 Sep; 24(9):1034-8. PubMed ID: 17490418
[TBL] [Abstract][Full Text] [Related]
30. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.
Ruessmann HJ;
J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218
[TBL] [Abstract][Full Text] [Related]
31. [The use of dipyridamole (curantyl) in combination with alpha-lipoic acid in the treatment of diabetic neuropathy with retinopathy].
Al-Zamil MKh
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):23-6. PubMed ID: 18833114
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
Foster TS
Diabetes Educ; 2007; 33(1):111-7. PubMed ID: 17272797
[TBL] [Abstract][Full Text] [Related]
33. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study.
Morcos M; Borcea V; Isermann B; Gehrke S; Ehret T; Henkels M; Schiekofer S; Hofmann M; Amiral J; Tritschler H; Ziegler R; Wahl P; Nawroth PP
Diabetes Res Clin Pract; 2001 Jun; 52(3):175-83. PubMed ID: 11323087
[TBL] [Abstract][Full Text] [Related]
34. [Thioctic (alpha-lipoic) acid-spectrum of clinical use].
Vorob'eva OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):86-90. PubMed ID: 22500323
[No Abstract] [Full Text] [Related]
35. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
[TBL] [Abstract][Full Text] [Related]
36. [Application of alpha-lipoic acid in clinical practice].
Lyzogub VH; Altunina NV; Bondarchuk OM
Lik Sprava; 2011; (7-8):20-8. PubMed ID: 22768734
[TBL] [Abstract][Full Text] [Related]
37. Pathogenetic treatments for diabetic peripheral neuropathy.
Ziegler D
Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110764. PubMed ID: 38245327
[TBL] [Abstract][Full Text] [Related]
38. Alpha lipoic acid and glycaemic control in diabetic neuropathies at type 2 diabetes treatment.
Ibrahimpasic K
Med Arch; 2013; 67(1):7-9. PubMed ID: 23678828
[TBL] [Abstract][Full Text] [Related]
39. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
[TBL] [Abstract][Full Text] [Related]
40. [Polyneuropathy--therapy].
Meyer FP
Dtsch Med Wochenschr; 2003 Mar; 128(11):572; author reply 572. PubMed ID: 12635035
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
